IP Library Granted Patent US 11,458,255
Granted Patent B2
US 11,458,255 · App. 16/332,025 · Granted Oct 4, 2022

Dose setting and indicator mechanism

Inventors: Karl James Hewson (Cambridgeshire, GB); George Bostock (Cambridgeshire, GB); George Robert Michael Savell (Cambridgeshire, GB); James Alexander Davies (Cambridgeshire, GB); Oliver Hart (Cambridgeshire, GB); Joshua Arieh Shenker (Cambridgeshire, GB)
Assignee: Norton Healthcare Limited
A61M5/31553A61M5/2033A61M5/24A61M5/31541A61M5/31585A61M2005/3126
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,458,255
App. No.
16/332,025
Granted
Oct 4, 2022
Kind
B2
Abstract

An injection device comprising a housing ( 112 ), and a dose selector ( 116 ) operatively connectable to a dose indicator positioned within the housing. The dose selector and the dose indicator ( 118, 119 ) are capable of cooperating to set a dose to be ejected from the injection device. The injection device further comprises a spring ( 120 ) capable of storing energy necessary for ejecting the dose from the injection device. The spring is locked to the dose indicator such that a charging force can be transferred from the dose selector to the spring via the dose indicator to increase the energy stored by the spring.

Claims (22)

1. An injection device comprising:

a. a housing having a longitudinal axis;

b. an axially-depressible dose button,

c. a dose indicator comprising an odometer positioned within the housing and arranged about said longitudinal axis;

d. a dose selector operatively connectable in series to the dose indicator, the dose selector and the dose indicator being capable of cooperating with one another to set a dose to be ejected from the injection device; and

e. a spring capable of storing energy necessary for ejecting the dose from the injection device;

wherein the spring is locked at one end to the dose indicator such that a charging force can be transferred in series from the dose selector to the spring via the dose indicator, when the dose selector is operatively connected to the dose indicator, to increase the energy stored by the spring;

wherein the odometer comprises a units wheel operatively connected to the dose selector so that rotation of the dose selector also rotates the units wheel, and a tens wheel selectively engageable with the units wheel so that rotation of the units wheel also rotates the tens wheel, and wherein the spring is coupled to the units wheel.

2. The injection device of claim 1 wherein the dose selector is operatively connectable to the dose indicator via a ratchet pawl, the ratchet pawl releasably engaging the dose selector and preventing counter-rotation of the dose indicator during dose setting, the ratchet pawl being disengageable from the dose selector by axial depression of the dose button.

3. The injection device of claim 2 wherein said charging force can be transferred from the dose selector to the spring via the engaged ratchet pawl and dose indicator.

4. The injection device of claim 1 wherein the spring is a torsion spring and the charging force transferred to the spring is a charging torque.

5. The injection device of claim 4 further comprising a drive assembly having a rotational to axial coupling, where the drive assembly is rotationally drivable by the torsion spring and is arranged to provide an axial force for ejecting the dose from the injection device.

6. The injection device of claim 5 wherein the drive assembly is rotationally drivable by the torsion spring via the dose indicator.

7. The injection device of claim 1 wherein the spring is directly locked to the dose indicator.

8. The injection device of claim 1 wherein the spring is locked to the dose indicator via one or more intermediate components capable of transmitting the charging force.

9. The injection device of claim 1 wherein the dose selector is directly coupled to the dose indicator.

10. The injection device of claim 1 wherein the dose selector is coupled to the dose indicator via one or more intermediate components capable of transmitting the charging force.

11. The injection device of claim 1 wherein the dose indicator is marked with a sequence of numbers or symbols, at least one of the numbers or symbols being visible through an aperture or window in the housing.

12. The injection device of claim 1 further comprising a medicament container.

13. The injection device of claim 12 wherein the medicament container comprises a pre-filled syringe or cartridge.

14. The injection device of claim 12 further comprising a medicament contained in the medicament container.

15. The injection device of claim 14 wherein the medicament is selected from the group comprising: antipsychotic substances including risperidone, hormones, antitoxins, substances for the control of pain, immunosuppressives, substances for the control of thrombosis, substances for the control or elimination of infection, peptides, proteins, human insulin or a human insulin analogue or derivative, polysaccharide, DNA RNA, enzymes, antibodies, oligonucleotide, antiallergics, antihistamines, anti-inflammatories, corticosteroids, disease modifying anti-rheumatic drugs, erythropoietin, or vaccines, for use in the treatment or prevention of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, hormone deficiency, toxicity, pain, thrombosis, infection, diabetes mellitus, diabetic retinopathy, acute coronary syndrome, angina, myocardial infarction, atherosclerosis, cancer, macular degeneration, allergy, hay fever, inflammation, anaemia, or myelodysplasia, or in the expression of protective immunity.

Assignments (1)
CONFIRMATORY ASSIGNMENT Recorded Aug 14, 2019
From: CAMBRIDGE DESIGN PARTNERSHIP
To: NORTON HEALTHCARE LIMITED
Reel/Frame 050716/0364 →
Priority Claims (1)
GB 1615433 · Sep 12, 2016 · national
Continuity (1)
Related Publication 20190358408A1 · Nov 28, 2019